Opendata, web and dolomites

PREDICT

PREDICT

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 PREDICT project word cloud

Explore the words cloud of the PREDICT project. It provides you a very rough idea of what is the project "PREDICT" about.

accurate    freedom    medical    exploring    makers    tackle    disorder    transcranial    solution    brain    impacts    people    burden    stimulation    tools    diagnosis    depression    anti    clear    cover    stages    eeg    health    elminda    researched    suicide    clinics    service    mental    decision    rates    software    benefits    disorders    intellectual    personalize    electrophysiological    conventional    tool    depressant    framework    supporting    time    caused    depressive    clinical    mdd    disabilities    positively    options    stakeholders    adoption    antidepressants    tms    generate    professional    patients    good    property    providers    shortage    predict    alternative    expectancy    feasibility    decisions    ip    efficacy    later    reduce    drug    treatment    optimizing    depressed    patient    treatments    social    clinicians    life    potentially    magnetic    informed    prediction    physicians    expanded    scope    intends    operate    improving    citizens    experiencing    disruptive    suggested    monitors    updated    innovative    light    technologies    society    economic    quality    psychiatric    optimized    invasive   

Project "PREDICT" data sheet

The following table provides information about the project.

Coordinator
ELMINDA LTD 

Organization address
address: Shenkar 1, WeWork Building
city: HERZLIYA
postcode: 4673314
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Israel [IL]
 Project website http://elminda.com
 Total cost 71˙429 €
 EC max contribution 50˙000 € (70%)
 Programme 1. H2020-EU.3.1.4. (Active ageing and self-management of health)
2. H2020-EU.2.1.1. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies - Information and Communication Technologies (ICT))
3. H2020-EU.2.3.1. (Mainstreaming SME support, especially through a dedicated instrument)
4. H2020-EU.3.1.6. (Health care provision and integrated care)
 Code Call H2020-SMEINST-1-2016-2017
 Funding Scheme SME-1
 Starting year 2018
 Duration (year-month-day) from 2018-02-01   to  2018-07-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    ELMINDA LTD IL (HERZLIYA) coordinator 50˙000.00

Map

 Project objective

Improving the current medical practice for mental health disorders such as depression, is a major concern for all stakeholders.The overall costs such as social and professional disabilities, increasing suicide rates, remain under-researched and their impacts are under-recognized by key decision-makers. In light of the economic and social burden caused by major depressive disorder (MDD), there is a strong need in the EU to provide citizens with adequate diagnosis and optimized treatment options. In this framework, PREDICT represents an innovative and disruptive tool; it is an EEG integrated software-based solution for physicians, which monitors brain electrophysiological activity with the scope of supporting and optimizing treatment decisions for depressed patients. The adoption of PREDICT in psychiatric clinics will positively affect patients, clinicians and it will potentially reduce costs for health service providers and for the whole society. Innovative technologies such as non-invasive Transcranial magnetic stimulation (TMS) offer a good alternative to the conventional antidepressants drug treatment. There is clear shortage in clinical PREDICTion tools which support better informed decisions and tackle the need to personalize the patient treatment. Our solution will provide a real-time, cost-effective method to assess TMS treatment efficacy and allow higher rates of treatment response. At later stages of product development, it will be expanded to cover PREDICTion to all available anti-depressant treatments. The suggested feasibility study will assess the overall economic benefits and will support ElMindA in exploring intellectual property opportunities through IP management and updated “Freedom to operate” analysis. By providing an accurate, simple to use cost-effective tool, our project intends to deliver an innovative solution that can generate a strong impact on society, increasing the quality of life and life expectancy of people experiencing major depression.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "PREDICT" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "PREDICT" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.1.4.;H2020-EU.2.1.1.;H2020-EU.2.3.1.;H2020-EU.3.1.6.)

CLINICOVERY (2018)

CLINICOVERY, a versatile, high quality, environmental-friendly, easy to use e-Clinical solution for clinical research

Read More  

ImmuneHunter (2017)

Bioinformatics platform for profiling of health: allowing early and accurate detection of multiple diseases simultaneously

Read More  

SensUS (2018)

SensUS: A non-invasive and quantitative ultrasound (QUS) device for an objective monitoring of the childbirth labour process.

Read More